India’s health ministry is planning to amend 72-year-old Drugs and Cosmetics Act in order to recognize medical devices as a separate category. There are currently only 14 medical devices regulated by the Drug Controller General of India (DCGI). Amending the Drugs and Cosmetics Act would bring all medical devices under regulation in India.
Troikaa Pharmaceuticals, a Gujarat based fast growing healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ.
Domestic drug companies, who have been challenging drug patents in the US and Europe, are now taking the first steps to challenge patents granted in India to companies based there.